Applied DNA Sciences (NASDAQ:APDN) Research Coverage Started at

Stock analysts at initiated coverage on shares of Applied DNA Sciences (NASDAQ:APDNGet Free Report) in a research report issued on Wednesday. The brokerage set a “hold” rating on the technology company’s stock.

Separately, HC Wainwright boosted their price target on Applied DNA Sciences from $1.50 to $7.00 and gave the stock a “buy” rating in a research report on Monday.

Check Out Our Latest Stock Report on APDN

Applied DNA Sciences Price Performance

APDN opened at $3.21 on Wednesday. The company has a market capitalization of $2.73 million, a PE ratio of -0.19 and a beta of 0.26. Applied DNA Sciences has a fifty-two week low of $2.50 and a fifty-two week high of $37.20. The business has a 50-day moving average of $7.27 and a 200-day moving average of $11.72.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Applied DNA Sciences stock. AMH Equity Ltd increased its stake in shares of Applied DNA Sciences, Inc. (NASDAQ:APDNFree Report) by 76.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 587,232 shares of the technology company’s stock after acquiring an additional 254,232 shares during the quarter. Applied DNA Sciences comprises approximately 0.9% of AMH Equity Ltd’s holdings, making the stock its 18th largest holding. AMH Equity Ltd owned 4.30% of Applied DNA Sciences worth $711,000 as of its most recent SEC filing. 22.22% of the stock is owned by hedge funds and other institutional investors.

About Applied DNA Sciences

(Get Free Report)

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.

Read More

Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with's FREE daily email newsletter.